Could Vaccination against COVID-19 Trigger Immune-Mediated Inflammatory Diseases?

COVID-19 flare hidradenitis immune-mediated inflammatory diseases onset vaccine

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
07 Aug 2024
Historique:
received: 08 07 2024
revised: 29 07 2024
accepted: 04 08 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 29 8 2024
Statut: epublish

Résumé

Exacerbations and new onset of immune-mediated inflammatory diseases, such as psoriasis and hidradenitis suppurativa, have been reported following COVID-19 vaccination. In patients with hidradenitis suppurativa, recent studies have shown that those who received mRNA vaccines were 3.5 times as likely to develop flares following vaccination compared to patients who received non-mRNA vaccines, indicating that mRNA COVID-19 vaccines are associated with hidradenitis suppurativa flares. Similar findings have been found in other studies evaluating the association between COVID-19 vaccines and other immune-mediated inflammatory diseases such as psoriasis, atopic dermatitis, lichen planus, and alopecia areata. However, further research is warranted in larger populations to validate these findings.

Identifiants

pubmed: 39200759
pii: jcm13164617
doi: 10.3390/jcm13164617
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Aikaterini I Liakou (AI)

1st Department of Dermatology-Venereology, "Andreas Sygros" Hospital, National and Kapodistrian University of Athens Medical School, 16121 Athens, Greece.

Andreas G Tsantes (AG)

Laboratory of Haematology and Blood Bank Unit, "Attikon" Hospital, National and Kapodistrian University of Athens Medical School, 12462 Athens, Greece.
Microbiology Department, "Saint Savvas" Oncology Hospital, 11522 Athens, Greece.

Eleni Routsi (E)

1st Department of Dermatology-Venereology, "Andreas Sygros" Hospital, National and Kapodistrian University of Athens Medical School, 16121 Athens, Greece.

Efthymia Agiasofitou (E)

1st Department of Dermatology-Venereology, "Andreas Sygros" Hospital, National and Kapodistrian University of Athens Medical School, 16121 Athens, Greece.

Magdalini Kalamata (M)

1st Department of Dermatology-Venereology, "Andreas Sygros" Hospital, National and Kapodistrian University of Athens Medical School, 16121 Athens, Greece.

Evangelia-Konstantina Bompou (EK)

1st Department of Dermatology-Venereology, "Andreas Sygros" Hospital, National and Kapodistrian University of Athens Medical School, 16121 Athens, Greece.

Konstantina A Tsante (KA)

Laboratory of Haematology and Blood Bank Unit, "Attikon" Hospital, National and Kapodistrian University of Athens Medical School, 12462 Athens, Greece.

Soultana Vladeni (S)

1st Department of Dermatology-Venereology, "Andreas Sygros" Hospital, National and Kapodistrian University of Athens Medical School, 16121 Athens, Greece.

Eleni Chatzidimitriou (E)

1st Department of Dermatology-Venereology, "Andreas Sygros" Hospital, National and Kapodistrian University of Athens Medical School, 16121 Athens, Greece.

Ourania Kotsafti (O)

1st Department of Dermatology-Venereology, "Andreas Sygros" Hospital, National and Kapodistrian University of Athens Medical School, 16121 Athens, Greece.

George Samonis (G)

Department of Medicine, University of Crete, 71500 Heraklion, Greece.
Department of Oncology, Metropolitan Hospital, 18547 Athens, Greece.

Stefanos Bonovas (S)

Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, Milan, Italy.
IRCCS Humanitas Research Hospital, 20089 Rozzano, Milan, Italy.

Alexander I Stratigos (AI)

1st Department of Dermatology-Venereology, "Andreas Sygros" Hospital, National and Kapodistrian University of Athens Medical School, 16121 Athens, Greece.

Classifications MeSH